NPPA panel fixes retail price of Zuventus antihypertensive FDC Efonidipine, telmisartan, details
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg manufactured and marketed by Zuventus Healthcare.
The retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare has been set at Rs 15.67 per tablet excluding GST
The recommendation came during the 39th meeting of the Multidisciplinary Committee of Experts held on February 25,2022, under the convenorship of Shri Manmohan Sachdeva, Advisor (Cost), through video-conferencing.
The issue of retail price fixation of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare Ltd under Para 5 of DPCO 2013 was analysed at the meeting.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.